Customized Contact Lens Treatments for In-the-eye Medication: Drug Delivery Through Contact Lenses - James Fick - Books - VDM Verlag - 9783639156126 - May 26, 2009
In case cover and title do not match, the title is correct

Customized Contact Lens Treatments for In-the-eye Medication: Drug Delivery Through Contact Lenses

Price
$ 76.49
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jun 26 - Jul 8
Add to your iMusic wish list

Hydrophilic polymer (polymacon, alphafilcon-A) and silicone-based (balafilcon-A) hydrogel contact lenses, before and after surface modification by radio-frequency glow-discharge treatment (RFGDT), were used to monitor methylene blue/silver nitrate drug-surrogate uptake and elution. Infrared spectroscopy revealed modified absorption peaks, accordingly. Energy-dispersive x-ray (EDX) analysis and inductively coupled argon plasma atomic emission spectroscopy (ICP) confirmed silver lens depot concentrations and were employed to measured eluate concentrations, while visible spectrophotometry and ICP spectrometry monitored methylene blue and silver elution rates in static versus simulated eye-blinking conditions. The conclusions reached are that (1) initial drug uptake of surface modified lenses increased in this order: polymacon < alphafilcon-A < balafilcon-A lenses; (2) drug release rates of the polymacon, and alphafilcon-A remained unaffected by the RFGDT; (3) increased release rates occurred from the RFGDT-surface-modified balafilcon-A lenses; and (4) dynamic forces increased the release rates for all contact lenses.

Media Books     Paperback Book   (Book with soft cover and glued back)
Released May 26, 2009
ISBN13 9783639156126
Publishers VDM Verlag
Pages 180
Dimensions 150 × 220 × 10 mm   ·   272 g
Language English  

Mere med samme udgiver